Rankings
▼
Calendar
ELVN FY 2019 Earnings — Enliven Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ELVN
Enliven Therapeutics, Inc.
$2B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$33,000
Operating Income
-$24M
Net Income
-$23M
EPS (Diluted)
$-5.43
Cash Flow
Operating Cash Flow
-$22M
Free Cash Flow
-$22M
Stock-Based Comp.
$899,000
Balance Sheet
Total Assets
$33M
Total Liabilities
$4M
Stockholders' Equity
-$49M
Cash & Equivalents
$5M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$33,000
$0
—
Operating Income
-$24M
-$11M
-125.9%
Net Income
-$23M
-$11M
-107.0%
← FY 2018
All Quarters
Q1 2019 →